Birkel explains that, when looking at mid-market versus large-market employers, there is a difference, with a higher percentage of the latter covering GLP-1s
In this form of polyneuropathy, the first nerve fibers to malfunction are those most distant from the central nervous system, with symptoms such as pain and numbness felt symmetrically in the feet, and then traveling up the legs as the condition progresses
You can read the full article at Tirzepatide (TZP), a new dual GIP/GLP-1 receptor agonist for treating type 2 diabetes (T2D), displayed superior outcomes in HbA1c reduction and patients achieving target levels compared to semaglutide and titrated insulin degludec across 40-weeks (SURPASS-2) and 52-weeks (SURPASS-3) studies
Retrieved March 4, 2015
Sean Kelishadi, MD FACS and reviewed by Sherry Kelishadi, Pharm.D
Heres what you should think about: 1